These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 104950)

  • 1. p-Hydroxyphenylacetaldoxime, an inhibitor of beta-galactosidase, produced by actinomycetes.
    Hazato T; Kumagai M; Naganawa H; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1979 Jan; 32(1):91-3. PubMed ID: 104950
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-Galactosidase-inhibiting new isoflavonoids produced by actinomycetes.
    Hazato T; Naganawa H; Kumagai M; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1979 Mar; 32(3):217-22. PubMed ID: 110760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactostatin, a new beta-galactosidase inhibitor from Streptomyces lydicus.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1987 Jan; 40(1):122-3. PubMed ID: 3104266
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyridindolol, a new beta-galactosidase inhibitor produced by actinomycetes.
    Aoyagi T; Kumagai M; Hazato T; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1975 Jul; 28(7):555-7. PubMed ID: 1150547
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure of pyridindolol, inhibitor of beta-galactosidase.
    Kumagai M; Naganawa H; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1975 Nov; 28(11):876-80. PubMed ID: 1201971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active-site-directed inactivation of Aspergillus oryzae beta-galactosidase with beta-D-galactopyranosylmethyl-p-nitrophenyltriazene.
    Mega T; Nishijima T; Ikenaka T
    J Biochem; 1990 Apr; 107(4):641-4. PubMed ID: 2113523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyconamides as inhibitors of human beta-glucosidases and beta-galactosidases.
    Chiao YB; Moffitt K; Smallwood Y; Glew RH; Naoi M; Lee YC
    Arch Biochem Biophys; 1979 Jan; 192(1):1-9. PubMed ID: 107857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma].
    Schulze E; Herrmann K; Haustein UF; Krusche U; Rothenburger I
    Dermatol Monatsschr; 1988; 174(11):661-6. PubMed ID: 3145222
    [No Abstract]   [Full Text] [Related]  

  • 9. Active site-directed inhibition of galactosidases by conduritol C epoxides (1,2-anhydro-epi- and neo-inositol).
    Legler G; Herrchen M
    FEBS Lett; 1981 Nov; 135(1):139-44. PubMed ID: 6274683
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on relationships between the structure and the glycosidase-inhibiting activity of HPAAO and its analogs.
    Hazato T; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1979 Mar; 32(3):212-6. PubMed ID: 572359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ineffectiveness of analogs of D-galactal as competitive inhibitors of, and substrates for, beta-D-galactosidase from Escherichia coli.
    Dettinger HM; Kurz G; Lehmann J
    Carbohydr Res; 1979 Sep; 74():301-7. PubMed ID: 114299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glycosaminoglycans on the in vitro activity of human skin fibroblast glycosphingolipid beta-galactosidases and neuraminidases.
    Rushton AR; Dawson G
    Clin Chim Acta; 1977 Oct; 80(1):133-9. PubMed ID: 409573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enzymatic conversion of p-hydroxyphenylacetaldoxime to p-hydroxymandelonitrile.
    Shimada M; Conn EE
    Arch Biochem Biophys; 1977 Apr; 180(1):199-207. PubMed ID: 193443
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of beta-Galactosidase by iodination of tyrosine-253.
    Huber RE; Fowler AV; Zabin I
    Biochemistry; 1982 Sep; 21(20):5052-5. PubMed ID: 6814483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [STUDY OF THE ORIGIN OF DIFFERENCES IN STABILITY PRESENTED BY NORMAL BETA-GALACTOSIDASE AND BETA-GALACTOSIDASE IN WHICH ALL THE TYROSINE GROUPS ARE REPLACED BY 3-FLUOROTYROSINE].
    MUNIER RL; SARRAZIN G
    C R Hebd Seances Acad Sci; 1964 Jul; 259():937-40. PubMed ID: 14190537
    [No Abstract]   [Full Text] [Related]  

  • 17. [DIFFERENCES EXISTING BETWEEN THE PROPERTIES OF NORMAL BETA-GALACTOSIDASE AND THOSE OF BETA-GALACTOSIDASE IN WHICH THE TYROSINE GROUPS ARE REPLACED BY 3-FLUOROTYROSINE].
    MUNIER RL; SARRAZIN G
    C R Hebd Seances Acad Sci; 1964 Jul; 259():677-80. PubMed ID: 14186909
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE SUBUNITS OF BETA-GALACTOSIDASE FROM E. COLI].
    WALLENFELS K; SUND H; WEBER K
    Biochem Z; 1963; 338():714-27. PubMed ID: 14087336
    [No Abstract]   [Full Text] [Related]  

  • 19. Strong inhibitory effect of furanoses and sugar lactones on beta-galactosidase Escherichia coli.
    Huber RE; Brockbank RL
    Biochemistry; 1987 Mar; 26(6):1526-31. PubMed ID: 3109465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis of a new type of iminosugar: a nitrogen atom is in the anomeric position.
    Ichikawa M; Ichikawa Y
    Bioorg Med Chem; 1995 Feb; 3(2):161-5. PubMed ID: 7796049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.